phase readout
saveNCT07198841: IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
RECRUITINGupdated 17d ago
community read0 votes
Sponsor: Guangdong Association of Clinical Trials. Phase: PHASE2. Conditions: Lung Cancer (Non-Small Cell)
view source ↗
comments(0)
5-min edit window · permanent after that